US Patent 7288542 Non-nucleoside reverse transcriptase inhibitors
All edits
Edits on 1 Sep, 2023
Golden AI
Edits made to:
Article (+409 characters)
Article
Patent abstract
The present invention relates to a compounds according to formula I, methods for treating diseases mediated by human immunodeficieny virus by administration of a compound according to formula I and pharmaceutical compositions for treating diseases mediated by human immunodeficieny virus containing a compound according to formula I where R1, R2, R3, R4, R5, R6, R7 and R8 are as defined herein
Edits on 21 Jul, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 14 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07288542 Non-nucleoside reverse transcriptase inhibitors US Patent 7288542 Non-nucleoside reverse transcriptase inhibitors
Infobox
Patent Number
0728854200
Patent Number
728854200
Edits on 30 Mar, 2023
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
072885420
Date of Patent
October 30, 2007
0Patent Application Number
110858690
Date Filed
March 22, 2005
0Official Website
Patent Primary Examiner
Edits on 26 Sep, 2022
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
072885420
Date of Patent
October 30, 2007
0Patent Application Number
110858690
Date Filed
March 22, 2005
0Official Website
Patent Primary Examiner
Edits on 17 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 23 Nov, 2021
Golden AI
Edits made to:
Infobox (+7 properties)
US Patent 07288542 Non-nucleoside reverse transcriptase inhibitors
Infobox
Is a
Patent jurisdiction
Patent number
07288542
Date of patent
October 30, 2007
Patent application number
11085869
Date Filed
March 22, 2005
Patent primary examiner
Find more entities like US Patent 7288542 Non-nucleoside reverse transcriptase inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
